Tempest Therapeutics
TPST
trading on NASDAQ
since 2021
$12.35
(Δ 54.28%)
+$4.31 since open
Tempest Therapeutics develops innovative mRNA-based medicines designed to address a range of serious health conditions, including viral infections, cancer, and autoimmune diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.90 | $8.64 | $7.70 | $21.91M | 223.33K |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$3.16 | n/a | +Inf | -Inf% | -Inf% | 0% |